Insider · CIK 0001410289

Szela Mary T

CIK 0001410289 Name as filed on the most recent filing

Filed as Szela Mary T (22)

76 transaction lines · from 22 filings · filed 2007-09-13 to 2026-07-06 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

76 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2026-06-30 P, Open-market purchase Absci CorpABSI 148,866, acquired Open Form 4 filing 0001672688-26-000124
2026-05-15 P, Open-market purchase TriSalus Life Sciences, Inc.TLSI 102,776, acquired Open Form 4 filing 0001628280-26-035994
2026-03-17 S, Open-market sale TriSalus Life Sciences, Inc.TLSI 61,384, disposed Open Form 4 filing 0001628280-26-020186
2026-03-11 S, Open-market sale TriSalus Life Sciences, Inc.TLSI 17,999, disposed Open Form 4 filing 0001628280-26-020186
2026-02-23 P, Open-market purchase TriSalus Life Sciences, Inc.TLSI 124,997, acquired Open Form 4 filing 0001628280-26-010603
2025-01-30 P, Open-market purchase TriSalus Life Sciences, Inc.TLSI 26,453, acquired Open Form 4 filing 0001415889-25-002536
2025-01-29 P, Open-market purchase TriSalus Life Sciences, Inc.TLSI 25,301, acquired Open Form 4 filing 0001415889-25-002536
2025-01-28 P, Open-market purchase TriSalus Life Sciences, Inc.TLSI 24,146, acquired Open Form 4 filing 0001415889-25-002292
2025-01-27 P, Open-market purchase TriSalus Life Sciences, Inc.TLSI 26,157, acquired Open Form 4 filing 0001415889-25-002292
2024-09-13 P, Open-market purchase TriSalus Life Sciences, Inc.TLSI 2 lines 36,255, acquired Open Form 4 filing 0001415889-24-023390
2024-09-12 P, Open-market purchase TriSalus Life Sciences, Inc.TLSI 39,104, acquired Open Form 4 filing 0001415889-24-023390
2024-09-10 P, Open-market purchase TriSalus Life Sciences, Inc.TLSI 24,850, acquired Open Form 4 filing 0001415889-24-023320
2020-06-22 S, Open-market sale Coherus BioSciences, Inc.CHRS 966,759, disposed Open Form 4 filing 0001567619-20-012534
2011-12-14 S, Open-market sale Abbott LaboratoriesABT 26 lines 2,893,724, disposed Open Form 4 filing 0001179110-11-016829
2011-03-31 S, Open-market sale Abbott LaboratoriesABT 2 lines 786,054, disposed Open Form 4 filing 0001179110-11-005770
2011-03-01 S, Open-market sale Abbott LaboratoriesABT 6 lines 830,862, disposed Open Form 4 filing 0001179110-11-003924
2011-02-28 S, Open-market sale Abbott LaboratoriesABT 96,026, disposed Open Form 4 filing 0001179110-11-003924
2010-03-01 S, Open-market sale Abbott LaboratoriesABT 245,340, disposed Open Form 4 filing 0001179110-10-004227

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 11
  • Open-market sale 65
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Szela Mary T, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001410289

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.